Event & Product News

Innovative micro-infusion pump from Gerresheimer subsidiary Sensile Medical for EVER Pharma

Düsseldorf/Olten, January 13, 2020 – Developed specially by Sensile Medical for EVER Pharma under the brand name D-mine®, this wearable micro-infusion pump has already been launched in several European countries. The compact, patient-friendly infusion pump is used for the continuous subcutaneous administration of drugs to treat Parkinson’s disease. The first micro pump from Gerresheimer subsidiary Sensile Medical to be available on the market, it gives Parkinson’s patients greater independence in their day-to-day lives.

The D-mine® pump is used to administer apomorphine in the advanced stages of Parkinson’s treatment. Simple handling, safety, and ease of use were the main aims behind the development. The compact design is down to Sensile Medical’s special micro-rotation pump technology and is straightforward to use thanks to an intuitive menu interface.

Parkinson’s patients often have difficulty moving and appreciate the pump’s ease of use, such as the automatic dosing function, the lack of complicated flow rate calculations, and the intuitive menu system. Its integrated choice of languages and the full-text display on its color screen make it easier to learn the ropes, while modern technologies such as data storage and individually adjustable basal rates support better treatment management. The D-mine® pump comes with a specially designed charging station and does not need any conventional batteries.

With its brand of the Parkinson’s drug apomorphine and its own medical product, EVER Pharma now offers a comprehensive treatment package. You can find more information at www.d-minecare.com.

At Pharmapack 2020 in Paris – Expo Porte de Versailles

Gerresheimer will present its sustainable and innovative packaging and administration solutions at the Pharmapack in Paris on February 5 and 6 at booth B60/B64 in hall 7.2.

About Gerresheimer

Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the Company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With our plants in Europe, North America, South America, and Asia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical pack-aging and products for the safe, simple administration of medicines: insulin pens, inhalers, micro pumps, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Contact
Contact us!
Communication & Marketing
Mail
Press
Phone
+49 211 61 81 246
Mail